..Publications
PEER REVIEWED - PUBLICATIONS

 

DR. STEWART HARRIS M.D., MPH, FCFP, FACPM
Professor
Department of Family Medicine
Family Physician
sharris1@uwo.ca

Biography
Non-Peer Reviewed Publications

PEER REVIEWED PUBLICATIONS

Publications 2007- March 2012

  1. Retnakaran R, Ye C, Hanley AJ, Harris SB, Zinman B. Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Diabetes Obes Metab. 2012 Jan;14(1):91-93.  

  2. Naqshbandi M, Harris SB, Macaulay AC, Comeau J, Piché J, Montour-Lazare D. Lessons learned in using community-based participatory research to build a national diabetes collaborative in Canada. Prog Community Health Partnersh. 2011 Winter (Nov);5(4):405-15. DOI: 10.1353/cpr.2011.0057.  

  3. Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, Perkins BA, Zinman B, Hanley AJ. Prospective associations of vitamin D with Beta-cell function and glycemia: the PROMISE PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes. 2011 Nov;60(11):2947-53.  

  4. Bhattacharyya OK, Rasooly IR, Naqshbandi M, Estey EA, Esler J, Toth E, Macaulay AC, Harris SB. Challenges to the provision of diabetes are in First Nations communities: results from a national survey of healthcare providers in Canada. BMC Health Serv Res. 2011 Oct 21;11:283.  

  5. He M, Harvey E, Harris SB, Beynon C, Mandich G, Battram D, Khoshaba L. Case study 5: addressing childhood obesity through a community-based strategy to screen and engage high-risk migrant families – families in action: a global village pediatric diabetes prevention resource. Public Health Agency of Canada.  Last accessed October 3, 2011. http://www.phac-aspc.gc.ca/cd-mc/diabetes-diabete/rhd-rds-2011/case5-cas5-eng.php.  

  6. Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M, Narasiah L, Kirmayer LJ, Ueffing E, MacDonald NE, Hassan G, McNally M, Khan K, Buhrmann R, Dunn S, Dominic A, McCarthy AE, Gagnon AJ, Rousseau C, Tugwell P and  s of the Canadian Collaboration for Immigrant and Refugee Health. Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 2011 Sep 6;183(12):E824-925.  

  7. Campbell NRC, Gilbert RE, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki RT, Harris SB. Hypertension in people with type 2 diabetes. Update on pharmacologic management. Can Fam Physician. 2011 Sep;57(9):997-1002,e347-53. Review. English, French. Erratum in: Can Fam Physician. 2011 Nov;57(11)1255.  

  8. Glazier R, Harris SB, Tompkins J, Wilton A, Chevendra V, Stewart M, Thind A. Number of HbA1c tests unrelated to quality of diabetes control: an electronic medical record data linkage study. Diabetes Res Clin Pract. 2011 Jul:93(1):e37-e40.  

  9. Retnakaran R, Qi Y, Harris SB, Hanley AJ, Zinman B. Changes over time in glycemic control, insulin sensitivity and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Diabetes Care. 2011 Jul;34(7):1601-4.  

  10. Harris SB, Naqshbandi M, Bhattacharyya O, Hanley AJG, Esler J, Zinman B, CIRCLE Study Group. Major gaps in diabetes clinical care among Canada’s First Nations: results of the CIRCLE study. Diabetes Res Clinl Pract. 2011 May;92:272-9, 2011. Epub 2011 Mar 3.  

  11. Mottola MF, Sopper MM, Doxtator L, Big-Canoe K, Prapavessis H, Harris S, Hanley A. Capacity-building and participatory research development of a community-based nutrition and exercise lifestyle intervention program (NELIP) for pregnant and post-partum Aboriginal women: information gathered from talking circles. International Indigenous Policy Journal. 2011; 2(1) Health and Well-being:Art. 8. Available at: http://ir.lib.uwo.ca/iipj/vol2/iss1/8.  

  12. He M, Piché L, Kurtz J, Beynon C, Harris SB. Screen-related sedentary behaviours of school-aged children: principals’ and teachers’ perspectives. Health Educ J. 2011 Mar 1;70(1):32-8.

  13. Cardiometabolic Risk Working Group: Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Despres JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol. 2011 Mar-Apr;27(2):e1-e33. Review.  

  14. Cardiometabolic Risk Working Group: Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Despres JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol. 2011 Mar-Apr;27(2):124-31. Review.  

  15. Ley S, Hegele RA, Harris SB, Mamakeesick M, Cao H, Connelly PW, Gittelsohn J, Retnakaran R, Zinman B, Hanley AJG. NF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study. BMC Med Genet. 2011 Jan 5;12:1.  

  16. Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC, Perkins BA, Zinman B, Hanley AJ. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and non-traditional components. J Clin Endocrinol Metab. 2011 Jan;96(1):168-75.  

  17. Harris SB, Glazier RH, Tompkins JW, Wilton AS,  Chevendra V, Stewart MA, Thind A. Investigating concordance in diabetes diagnosis between primary care charts (electronic medical records) and health administrative data: a retrospective cohort study. BMC Health Serv Res.  2010 Dec 23;10:347.  

  18. Harris SB, Kapor J, Lank CN, Willan AR, Houston T. Clinical inertia in patients withT2DM requiring insulin in family practice. Can Fam Physician. 2010 Dec;56(12):e418-e24.  

  19. Teoh H, Braga MFB, Casanova A, Drouin D, Goodman SG, Harris SB, Langer A, Tan MK, Ur E, Yan AT, Zinman B, Leiter LA on behalf of the T2DM QUERI Investigators. Patient age, ethnicity, medical history and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets. Time 2 Do More Qualitative Enhancement Research Initiative (T2DM QUERI). Diabetes Care. 2010 Dec;33(12):2558-60. Epub 2010 Sep 7.  

  20. He M, Piché L, Clarson C, Callaghan C, Harris SB. Childhood overweight and obesity management: a national perspective of primary health care providers’ views, practices, perceived barriers and needs. Paediatri Child Health. 2010 Sep;15(7):419-26.  

  21. Bhattacharyya OK, Harris SB, Zwarenstein M, Barnsley J. Controlled trial of an intervention to improve cholesterol management in diabetes in remote Aboriginal communities. Int J Circumpolar Health. 2010 Sep;69(4):333-43. Epub 2010 Jun 18.  

  22. Ley SH, Hegele R A, Connelly PW, Harris SB, Mamakeesick M, Cao H, Gittelsohn J, Retnakaran R, Zinman B, Hanley AJG. Assessing the association of HNF1A/G319S variant with-reactive protein in Aboriginal Canadians: a  population-based epidemiological study. Cardiovasc Diabetol. 2010 Aug18;9:39.  

  23. Zinman B, Harris SB, Neuman J, Gerstein HC, Retnakara R, Raboud J, Qi Y, Hanley AJ. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet. 2010 Jul;376(9735):103-11.  

  24. Braga MB, Casanova A, Teoh H, Dawson KG, Gerstein HC, Fitchett D, Harris SB, Honos G, McFarlane P, Steele A, Ur E, Yale J-F, Langer A, Goodman SG, Leiter LA; Diabetes Registry to Improve Vascular Events (DRIVE) Investigators. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol. 2010 Jun-Jul;26(6):297-302.  

  25. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Ying Q, Gerstein HC, Perkins B, Harris SB, Zinman B, Hanley AJG. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk of type 2 diabetes. Diabetes Care. 2010 Jun;33(6):1379-81, Epub 2010 Mar 9. Erratum in: Diabetes Care. 2011 Jan;34(1):247.  

  26. He M, Li E, Harris SB, Huff MW, Yau CY, Anderson G. Canadian global village reality: anthropometric surrogate cutoffs and metabolic abnormalities among Canadians of East-Asian, South-Asian and European descent. Can Fam Physician. 2010 May;56(5):e174-82.  

  27. Tompkins JW, Luginaah IN, Booth GL, Harris SB. The geography of diabetes in London, Canada: the need for local level policy for prevention and management. International Journal of Environmental Research and Public Health, 2010 May;7(5):2407–22. Epub 2010 May 19.  

  28. Lahiry P, Cao H, Ban MR, Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hanley AJG, Huff MW, Connelly PW, Hegele RA. APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-1 in Aboriginal Canadians. J Lipid Res. 2010 Apr;51(4):843-8.  

  29. Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele R A, Zinman B, Hanley AJ. Association of apolipoprotein B with incident type 2 diabetes in an Aboriginal Canadian population. Clin Chem. 2010 Apr;56(4):666-70. Epub 2010 Jan 28.  

  30. Mottola MF, Giroux I, Gratton R, Hammond J-A, Hanley A, Harris SB, McManus R, Davenport, MH, Sopper MM. Nutrition and exercise prevents excess weight gain in  overweight pregnant women. Med Sci Sports Exec. 2010 Feb; 42(2):265-72.  

  31. He M, Piche L, Beynon, C, Harris SB. Screen-related sedentary behaviors: children’s and parents’ attitudes, motivation and practices. JNEB. 2010 Jan;42(1):17-25.  

  32. Hanley AJG, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, Harris SB, Zinman B. The Association of Hematological Parameters with Insulin Resistance and Beta-Cell Dysfunction in Non-diabetic Subjects: The PROspective Metabolism and Islet cell Evaluation (PROMISE). Journal of Clinical Endocrinology & Metabolism 94(10):3824-3832, 2009.  

  33. Connelly PW, Zinman B, Maguire GF, Mamakeesick M, Harris SB, Hegele RA, Retnakaran R, Hanley AJG. Association of the Novel Cardiovascular Risk Factors Paraoxonase 1 and Cystatin C in Type 2 Diabetes. Journal of the American Society of Nephrology. Journal of Lip Research 50:1216-1222, 2009.  

  34. He M, Harris S, Piché L, Beynon C, Evans A, Swan J, Radcliffe D. Understanding Screen-Related Sedentary Behavior and its Contributing Factors among School-aged Children: A Social-Ecological Exploration. American Journal of Health Promotion 23(5):299-308, 2009. Co-

  35. Biderman A, Noff E, Harris SB, Frideman N, Levy A. Treatment satisfaction of diabetic patients: What are the contributing factors? Fam Pract 26(2):102-108, 2009, doi: 10.1093/fampra/cmp007.  

  36. Ley SH, Harris SB, Mamakeesick M, Noon T, Fiddler E, Gittelsohon J, Wolever TM, Connelly P, Hegele RA, Zinman B, Hanley A JG. Metabolic Syndrome and Its Components as Predictors of Incident Type 2 Diabetes Mellitus in an Aboriginal Community. CMAJ 180(6):617-624, 2009.  

  37. Thorpe C, Ryan B, McLean S, Burt A, Stewart M, Brown JB, Reid G, Harris SB. How to obtain excellent response rates when surveying physicians. Fam Pract 26(1):65-68, 2009.  

  38. Rosenstock J, Hollander P, Chevalier S, Iranmanesh A. The SERENADE Study Group. The SERENADE Trial: Effects of Monotherapy with Rimonabant, the First Selective CB1 Receptor Antagonist, on Glycemic Control, Body Weight and Lipid Profile in Drug-Naïve Type 2 Diabetes. Diabetes Care 31:2169-2176, 2008.  

  39. Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F. Global Complication Rates of Type 2 Diabetes in Indigenous Peoples: A Comprehensive Review. Diabetes Research and Clinical Practice 82(1):1-17, 2008. http://dx.doi.org/10.1016/j.diabres.2008.07.017.

  40. Dahan R, Reis S, Borkan J, Brown JB, Hermoni D, Mansor N, Harris S. Is Knowledge a Barrier to Implementing Low Back Pain Guidelines? Assessing the Knowledge of Israeli Family Doctors. Journal of Evaluation in Clinical Practice 14(5):785-791, 2008.  

  41. Stone JA, Austford L, Parker J, Gledhill N, Tremblay G, Arthur H on behalf of the Canadian Vascular Coalition. AGREEing on Canadian Cardiovascular Clinical Practice Guidelines. Canadian Journal of Cardiology 24(10):753-757, 2008.  

  42. Salsberg J, Louttit S, McComber AM, Fiddler R, Naqshbandi M, Receveur O, Harris SB, Macaulay AC. Knowledge, Capacity and Readiness: Translating Successful Experiences in Community-Based Participatory Research for Health Promotion. Pimatisiwin: A Journal of Indigenous and Aboriginal Community Health 5(2):125-150, 2008.

  43. Ho L, Gittelsohn J, Sharma S, Cao X, Treuth M, Rimal R, Ford E, Harris SB. Food Related Behaviour, Physical Activity, and Dietary Intake in First Nations: A Population at High Risk for Diabetes. Society of Public Health Education. Ethnicity and Health 13(4):335-349, 2008.  

  44. Harris S, (Steering Committee). Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 32(Supplement 1):S1-S201, 2008.  

  45. Leiter L, Genest J, Harris SB, Lewis G, McPherson R, Steiner G, Woo V, (Canadian Diabetes Association Clinical Practice Guidelines Expert Committee). Dyslipidemia. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 32(Supplement 1):S107-S114, 2008.  

  46. Dannenbaum D, Dawson KG, Harris SB, Wortman J, (Canadian Diabetes Association Clinical Practice Guidelines Expert Committee). Type 2 Diabetes in Aboriginal Peoples. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 32(Supplement 2):S187-S190, 2008.  

  47. Harvey El, Harris SB, Sohal P, (Canadian Diabetes Association Clinical Practice Guidelines Expert Committee). Type 2 Diabetes in High-risk Ethnic Populations. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 32(Supplement 1):S191-S193, 2008.  

  48. Ho L, Gittelsohn J, Rimal R, Treuth M, Sharma S, Rosecrans A, Harris SB, An Integrated Multi-institutional Diabetes Prevention Program Improves Knowledge and Healthy Food Acquisition in Northwestern Ontario First Nations. Health Education & Behaviour 35(4):561-573, 2008.  

  49. Sharma S, Cao X, Gittelsohn J, Ho LS, Rosecrans A, Harris SB, Hanley AJG, Zinman B. Dietary Intake and Development of a Quantitative Food Frequency Questionnaire for a Lifestyle Intervention to Reduce Risk of Chronic Diseases in Canadian First Nations in Northwestern Ontario. Public Health Nutrition 11(8):831-840, 2008.  

  50. Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Hegele RA, Retnakaran R, Zinman B, Hanley AJG. Adipokines and Incident Type 2 Diabetes in a Canadian Aboriginal Population: The Sandy Lake Health and Diabetes Project. Diabetes Care 31(7):1410-1415, 2008.  Erratum in: Diabetes Care. 2008 Aug; 31(8):1713.  

  51. Ceriello A, Colagiuri S, Gerich J. (Harris, Stewart B.–member of Guideline Development Group). Guideline for Management of Postmeal Glucose. Nutrition, Metabolism & Cardiovascular Diseases 18(4):S17-S33, 2008.  

  52. The DREAM Trial Investigators. Effects of Ramipril and Risiglitazone on Cardiovascular and Renal Outcomes in People with Impaired Glucose Tolerance or Impaired Fasting Glucose. Results of the Diabetes Reduction Assessment with ramipril and rosiglitazone Medication (DREAM) trail. Diabetes Care 31(5):1007-1014, 2008.  

  53. Terry AL, Thorpe CF, Giles G, Brown JB, Harris SB, Reid G, Thind A, Stewart M. Implementing electronic health records: key factors in primary care. Can Fam Physician. 2008 May;54(5):730-6.  

  54. Harris SB, Yale J-F, Dempsey E, Gerstein HC. Can Family Physicians Help Patients Initiate Basal Insulin Therapy Successfully? Randomized Trial of Patient-titrated Insulin Glargine Compared with Standard Oral Therapy: Lessons for Family Practice from the Canadian INSIGHT Trial. Canadian Family Physician 54(4):550-558, 2008.  

  55. Al-Attar SA, Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJG, Connelly PW, Huff MW Hegele RA. Association between the FTO rs9939609 Polymorphism and the Metabolic Syndrome in a Non-Caucasian Multi-ethnic Sample. Cardiovascular Diabetology March 13; 7:5, 2008.  

  56. Rosecrans A, Gittelsohn J, Ho LS, Harris SB, Naqshbanchi M, Sharma S. Process Evaluation of a Multi-institutional Community-Based Program among First Nations. Health Education Research 23(2):272-286, 2008.

  57. Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJG, Connelly PW, Huff MW Hegele RA. Association between the -455T>C promoter polymorphism of the apolipoprotein C-III gene and the metabolic syndrome in a multi-ethnic sample. BMC Med Genet.2007 Dec 20;8:80:1-7. doi:10.1186/1471-2350-8-80.  

  58. Houlden R, Ross S, Harris S, Yale J-F, Sauriol L, Gerstein Hertzel C. Treatment Satisfaction and Quality of Life using an Early Insulinization Strategy with Insulin Glargine Compared to an Adjusted Oral Therapy in the Management of Type 2 Diabetes: The Canadian INSIGHT Study. Diabetes Research and Clinical Practice 78(2):254-258, 2007.  

  59. Dahan R, Borkan J, Brown JB, Reis S, Hermoni D, Harris SB. The challenge of using the low back pain guidelines: a qualitative research. J Eval Clin Pract. 2007 Aug; 13(4):616-20.  

  60. Retnakaran R, Connelly PW, Harris SB, Zinman B, Hanley AJG. Cystatin C is Associated with Cardiovascular Risk Factors and Metabolic Syndrome in Aboriginal Youth. Pediatric Nephrology 22(7):1007-1013, 2007.

  61. Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hegele RA, Hanley AJ. Peroxisome Proliferator-activated Receptor Gamma Polymorphism Pro12A1a is Associated with Nephropathy in Type 2 Diabetes. Journal of Diabetes and Its Complications 21(3):166-171, May-June 2007.  

  62. Harris SB, Leiter LA, Yale J-F, Chiasson J-L, Kleinstiver P, Sauriol L. Out-of-pocket Costs of Managing Hyperglycemia and Hypoglycemia in Patients with Type 1 Diabetes and Insulin-treated Type 2 Diabetes. Canadian Journal of Diabetes 31(1):25-33, 2007.  

  63. Thind A, Thorpe C, Burt A, Stewart M, Reid G, Harris S, Brown JB. Determinants of Waiting Time for a Routine Family Physician Consultation in Southwestern Ontario. Healthcare Policy 2:1-14 (Online Exclusive) February, 2007.  


Back to Top | Back to Publications